|
Bristol reports loss, charges offset strong sales
2008-01-31
Bristol-Myers Squibb Co on Thursday reported a loss from continuing operations as special charges more than offset strong sales growth of its array of prescription drugs. The New York-based drugmaker said it lost $133 million, or 7 cents per share. That compared with a loss from continuing operations of $170 million, or 9 cents per share, in the year-ago period when the company took charges to retire debt and finance the proposed settlement of a federal probe into its marketing practices. Excluding special items, Bristol-Myers earned 33 cents per share. (Reporting by Ransdell Pierson, editing by Maureen Bavdek)
|